Your browser doesn't support javascript.
loading
Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification.
Agersborg, Sally; Mixon, Christopher; Nguyen, Thanh; Aithal, Sramila; Sudarsanam, Sucha; Blocker, Forrest; Weiss, Lawrence; Gasparini, Robert; Jiang, Shiping; Chen, Wayne; Hess, Gregory; Albitar, Maher.
Afiliación
  • Agersborg S; NeoGenomics Laboratories, Research and Development, 31 Columbia, Aliso Viejo, CA, 92656, USA.
  • Mixon C; NeoGenomics Laboratories, Research and Development, 31 Columbia, Aliso Viejo, CA, 92656, USA.
  • Nguyen T; NeoGenomics Laboratories, Research and Development, 31 Columbia, Aliso Viejo, CA, 92656, USA.
  • Aithal S; Cancer Treatment Centers of America, Philadelphia, PA, USA.
  • Sudarsanam S; NeoGenomics Laboratories, Research and Development, 31 Columbia, Aliso Viejo, CA, 92656, USA.
  • Blocker F; NeoGenomics Laboratories, Research and Development, 31 Columbia, Aliso Viejo, CA, 92656, USA.
  • Weiss L; NeoGenomics Laboratories, Research and Development, 31 Columbia, Aliso Viejo, CA, 92656, USA.
  • Gasparini R; NeoGenomics Laboratories, Research and Development, 31 Columbia, Aliso Viejo, CA, 92656, USA.
  • Jiang S; NeoGenomics Laboratories, Research and Development, 31 Columbia, Aliso Viejo, CA, 92656, USA.
  • Chen W; NeoGenomics Laboratories, Research and Development, 31 Columbia, Aliso Viejo, CA, 92656, USA.
  • Hess G; Symphony Health, Conshohocken, PA, USA.
  • Albitar M; NeoGenomics Laboratories, Research and Development, 31 Columbia, Aliso Viejo, CA, 92656, USA. maheralbitar@gmail.com.
Breast Cancer Res Treat ; 170(2): 321-328, 2018 Jul.
Article en En | MEDLINE | ID: mdl-29564742

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Inmunohistoquímica / Biomarcadores de Tumor / Hibridación Fluorescente in Situ / Receptor ErbB-2 Tipo de estudio: Risk_factors_studies Idioma: En Revista: Breast Cancer Res Treat Año: 2018 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Inmunohistoquímica / Biomarcadores de Tumor / Hibridación Fluorescente in Situ / Receptor ErbB-2 Tipo de estudio: Risk_factors_studies Idioma: En Revista: Breast Cancer Res Treat Año: 2018 Tipo del documento: Article